Health product recall

Renadyl(2021-06-04)

Starting date:
June 4, 2021
Type of communication:
Drug Recall
Subcategory:
Natural Health Products - Homeopathic Medicine
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-75799

Last updated:
2021-06-10

Summary

  • Product:
    Renadyl

Reason

The affected lots contain an undeclared ingredient (inulin) and are missing risk statements on the label.

Depth of distribution

Retailers

Affected products

Renadyl

DIN, NPN, DIN-HIM

NPN 80036014

Dosage form

Capsule

Strength

Bifidobacterium longum subsp. longum 15.0 billion cfu
Lactobacillus acidophilus 15.0 billion cfu
Streptococcus salivarius subsp. thermophilus 15.0 billion cfu

Lot or serial number

5421119B,5420320A,5420720B,5420820

Companies

Recalling Firm

Gelda Scientific and Industrial Development Corporation

6320 Northwest Drive

Mississauga

L4V 1J7

Ontario

CANADA

Marketing Authorization Holder

Gelda Scientific and Industrial Development Corporation

6320 Northwest Drive

Mississauga

L4V 1J7

Ontario

CANADA